US FDA’s April User Fee Goals Give Biologics Center A Chance To Shift 2026 Narrative

 
• By Bridget Silverman
  
Sponsors including Orca Bio, Replimune, AbbVie and Merck are hoping their applications blossom into approvals this April (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Product Reviews